Psychemedics Corporation
PMD was delisted on the 12th of December, 2024.
58 hedge funds and large institutions have $79.4M invested in Psychemedics Corporation in 2017 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 22 increasing their positions, 18 reducing their positions, and 4 closing their positions.
125% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 4
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
34% more capital invested
Capital invested by funds: $59.3M → $79.4M (+$20.1M)
22% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 18
9% more funds holding
Funds holding: 53 → 58 (+5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Ativo Capital Management
Chicago,
Illinois
|
+$1.2M |
| 2 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
+$701K |
| 3 |
SCP
Seizert Capital Partners
Birmingham,
Michigan
|
+$624K |
| 4 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$529K |
| 5 |
MC
Moors & Cabot
Boston,
Massachusetts
|
+$498K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tieton Capital Management
Yakima,
Washington
|
-$652K |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$355K |
| 3 |
Renaissance Technologies
New York
|
-$229K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$215K |
| 5 |
LAM
Lapides Asset Management
Greenwich,
Connecticut
|
-$215K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Barclays
London,
United Kingdom
| $20K | +$7.69K | +366 | +82% |
|
52
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $11K | -$42 | -2 | -0.4% |
|
|
PFBT
53
Parkside Financial Bank & Trust
Saint Louis,
Missouri
| $11K | +$9.46K | +450 | New |
|
54
Royal Bank of Canada
Toronto,
Ontario, Canada
| $9K | -$21 | -1 | -0.3% |
|
|
AG
55
Advisor Group
Phoenix,
Arizona
| $7K | – | – | – |
|
56
Fifth Third Bancorp
Cincinnati,
Ohio
| $7K | – | – | – |
|
57
UBS Group
Zurich,
Switzerland
| $3K | -$41.6K | -1,979 | -95% |
|
|
MA
58
MUFG Americas
New York
| $2K | -$862 | -41 | -29% |
|
|
OAM
59
Oxford Asset Management
Oxford,
United Kingdom
| – | -$355K | -17,700 | Closed |
|
|
GCP
60
GSA Capital Partners
London,
United Kingdom
| – | -$215K | -10,700 | Closed |
|
|
LAM
61
Lapides Asset Management
Greenwich,
Connecticut
| – | -$215K | -10,700 | Closed |
|
|
SCM
62
Segantii Capital Management
Hong Kong
| – | -$113K | -5,650 | Closed |
|
PMD Hedge Fund Activity: Q2 2017 in Review
58 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Psychemedics Corporation (PMD) for Q2 2017, worth a combined $79.4M — up 34% from $59.3M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new PMD positions and 4 closed out — a net gain of 5 holders — while 22 added to existing stakes and 18 trimmed.
The largest buyer was Ativo Capital Management, opening a new position worth an estimated $1.2M. The largest seller was Tieton Capital Management, cutting an estimated $652K.
- 58 institutional investors held Psychemedics Corporation (PMD) as of Q2 2017, up from 53 in Q1 2017.
- Funds reported $79.4M of Psychemedics Corporation stock for Q2 2017, up 34% quarter-over-quarter.
- 9 funds opened new Psychemedics Corporation positions in Q2 2017 and 4 closed out, a net change of +5 holders.
- The largest Psychemedics Corporation buyer in Q2 2017 was Ativo Capital Management, an estimated $1.2M added.
- The largest Psychemedics Corporation seller in Q2 2017 was Tieton Capital Management, an estimated $652K sold.
Based on aggregated 13F filings for Q2 2017.